Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

MRI-Based Prediction of Dienogest Response in Endometriosis

The goal of this prospective observational study is to learn whether magnetic resonance imaging (MRI) findings can help predict treatment response to dienogest in women with endometriosis. Endometriosis is a common gynecologic condition that can cause chronic pelvic pain and negatively affect quality of life. Although dienogest is widely used as a standard medical treatment, individual responses to treatment vary. The main questions this study aims to answer are: * Whether baseline MRI characteristics of endometriotic lesions are associated with improvement in pelvic pain after dienogest treatment. * Whether MRI findings can help identify patients who are more likely to benefit from dienogest therapy. Participants diagnosed with endometriosis who are prescribed dienogest as part of their routine clinical care will be enrolled. This study does not assign any investigational intervention. Participants will undergo standard clinical follow-up, including pelvic pain assessment using visual analog scale (VAS) scores, quality of life questionnaires, and routine MRI examinations. Clinical and imaging data will be collected prospectively and analyzed to explore imaging predictors of treatment response.

Participants needed: 48
Trial details
Age: 19-45Biological sex: FemaleType: ObservationalSponsor: Chungnam National University Sejong HospitalUpdated: Mar 3, 2026Locations: 1
Eligibility criteria

Female participants who have received a full explanation of the study and have p... [+3]

Patients with a history of treatment with dienogest [+4]

Status: Not yet recruiting

Thoracic Mobilization for Restrictive Lung Disease

This study aims to investigate the immediate effects of thoracic mobilization techniques on cough capacity, dyspnea, and pulmonary function in patients with restrictive lung disease. The intervention will be applied in a single session, and outcomes will be measured before and after the intervention to evaluate short-term physiological changes.

Participants needed: 24
Trial details
Age: 19+Biological sex: AllType: InterventionalSponsor: Chungnam National University Sejong HospitalUpdated: Jun 10, 2025Locations: 1
Eligibility criteria

Age 19 years or older [+4]

FEV1/FVC ratio < 70% [+1]